News Releases
Nov 1 2002
Peregrine Pharmaceuticals Provides Update On Status Of Cotara Phase III
Oct 22 2002
Peregrine Pharmaceuticals Reports Voting Results of Annual Meeting
Sep 19 2002
Peregrine Pharmaceuticals Provides Update on Status of Cotara Phase III
Sep 17 2002
Peregrine Pharmaceuticals Announces Grant of Patent for New Vascular Targeting Agents
Sep 12 2002
Peregrine Pharmaceuticals Presents Vascular Targeting Agent Platform At the 2002 Antibody World Summit; Company Announces Quarterly Conference Call
Aug 22 2002
Peregrine Pharmaceuticals Receives Notice From Nasdaq to Start 180-Day Grace Period to Regain Compliance with Nasdaq Listing Requirements
Aug 13 2002
Peregrine Pharmaceuticals Announces $1,856,000 Investment from Institutional Investor; Over $10 Million in Cash and Cash Commitments on Hand; Conference Call Set for 11:00 AM EDT, Aug. 15
Aug 12 2002
Peregrine Pharmaceuticals Announces $7.1 Million Private Investment Commitment From Institutional Investors
Jul 29 2002
Peregrine Pharmaceuticals Submits Extension to File Its Annual Report On Form 10-K; Quarterly Conference Call To Be Rescheduled
Jul 24 2002
Peregrine Pharmaceuticals' Quarterly Conference Call Rescheduled for Tuesday, July 30